
Accomplished director with strong relationship-building and decision-making skills. Demonstrated success in securing key partnerships and leveraging industry insights to shape strategic initiatives and enhance market access.
• HUTCHMED USA brand formulary launch preparation and payer information exchanges with all large national payers/PBMs (UHG, CVS Aetna.), community oncology & IDN pharmacy (NCODA), Group Purchasing Organizations (GPO’s), Specialty Trade/Distribution, and NCCN. • National brand related business development landscape and strategy critical to establishing payer/PBM related access reviews. • Patient and provider reimbursement support strategies necessary to successfully navigating payer/PBM medical exception processes upon brand FDA approval and launch. • Specialty pharmacy and specialty distribution trade, strategy, and implementation. • Rare disease/oncology Clinical Pathways planning, strategy, and engagement. • Onco360, Optum, & CVS Health specialty pharmacy contracting & engagement.
Directed partnerships with oncology GPOs and institutional accounts to foster strategic relationships with C-suite executives. Led cross-functional teams in evaluating competitive landscapes and identifying key market opportunities. Developed and executed targeted market objectives and tactics to drive business performance. Negotiated and implemented innovative contracts that supported national brand strategies. Oversaw product performance analysis at the national level and engaged with key stakeholders to ensure alignment.
NCODA
HOPA
COA